688 related articles for article (PubMed ID: 19741579)
1. New stents for SFA.
MINAR E; SCHILLINGER M
J Cardiovasc Surg (Torino); 2009 Oct; 50(5):635-45. PubMed ID: 19741579
[TBL] [Abstract][Full Text] [Related]
2. Past, present and future of femoropopliteal stenting.
Schillinger M; Minar E
J Endovasc Ther; 2009 Feb; 16 Suppl 1():I147-52. PubMed ID: 19317587
[TBL] [Abstract][Full Text] [Related]
3. Evolving modalities for femoropopliteal interventions.
Ansel GM; Lumsden AB
J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II82-97. PubMed ID: 19624076
[TBL] [Abstract][Full Text] [Related]
4. Primary nitinol stenting for femoropopliteal disease.
Mewissen MW
J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II63-81. PubMed ID: 19624075
[TBL] [Abstract][Full Text] [Related]
5. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
7. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year.
Davaine JM; Quérat J; Guyomarch B; Brennan MÁ; Costargent A; Chaillou P; Patra P; Gouëffic Y
Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):201-12. PubMed ID: 23773773
[TBL] [Abstract][Full Text] [Related]
8. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
[TBL] [Abstract][Full Text] [Related]
9. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.
Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Cao AY; Jaff MR;
J Endovasc Ther; 2012 Feb; 19(1):1-9. PubMed ID: 22313193
[TBL] [Abstract][Full Text] [Related]
10. Incidence of stent fractures and patency after femoropopliteal stenting with the nitinol self-expandable SMART stent: a single-center study.
Trabattoni D; Agrifoglio M; Cappai A; Bartorelli AL
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):678-82. PubMed ID: 20216226
[TBL] [Abstract][Full Text] [Related]
11. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries.
Sabeti S; Mlekusch W; Amighi J; Minar E; Schillinger M
J Endovasc Ther; 2005 Feb; 12(1):6-12. PubMed ID: 15683273
[TBL] [Abstract][Full Text] [Related]
12. Comparison of drug-eluting balloon angioplasty with self-expanding interwoven nitinol stent deployment in patients with complex femoropopliteal lesions.
Teymen B; Akturk S; Akturk U; Tdjani M
Vascular; 2018 Feb; 26(1):54-61. PubMed ID: 28708023
[TBL] [Abstract][Full Text] [Related]
13. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis.
Sabeti S; Schillinger M; Amighi J; Sherif C; Mlekusch W; Ahmadi R; Minar E
Radiology; 2004 Aug; 232(2):516-21. PubMed ID: 15286322
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in self-expanding stents for use in the superficial femoral and popliteal arteries.
Aghel A; Armstrong EJ
Expert Rev Cardiovasc Ther; 2014 Jul; 12(7):833-42. PubMed ID: 24830846
[TBL] [Abstract][Full Text] [Related]
15. Management of flush superficial femoral artery occlusions with combined open femoral endarterectomy and endovascular femoral-popliteal angioplasty and stent-grafting.
Hayes DJ; Dougherty MJ; Calligaro KD
Ann Vasc Surg; 2011 May; 25(4):559.e19-23. PubMed ID: 21549939
[TBL] [Abstract][Full Text] [Related]
16. The role of stent-grafts for prevention and treatment of restenosis.
Kwa AT; Yeo KK; Laird JR
J Cardiovasc Surg (Torino); 2010 Aug; 51(4):579-89. PubMed ID: 20671643
[TBL] [Abstract][Full Text] [Related]
17. A network meta-analysis of randomized controlled trials comparing treatment modalities for de novo superficial femoral artery occlusive lesions.
Antonopoulos CN; Mylonas SN; Moulakakis KG; Sergentanis TN; Sfyroeras GS; Lazaris AM; Kakisis JD; Vasdekis SN
J Vasc Surg; 2017 Jan; 65(1):234-245.e11. PubMed ID: 27865639
[TBL] [Abstract][Full Text] [Related]
18. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.
Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Jaff MR;
Circ Cardiovasc Interv; 2010 Jun; 3(3):267-76. PubMed ID: 20484101
[TBL] [Abstract][Full Text] [Related]
19. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
Tomoi Y; Soga Y; Iida O; Shiraki T; Kobayashi Y; Hiramori S; Ando K
J Endovasc Ther; 2016 Jun; 23(3):461-7. PubMed ID: 27004496
[TBL] [Abstract][Full Text] [Related]
20. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
